Emgality approval date?

When was Emgality first approved?

Emgality (galcanezumab) received its first U.S. approval on September 19, 2018. [1]

What approval date should you use for U.S. coverage vs. other countries?

The approval date above is the U.S. FDA approval date for Emgality. If you meant a specific non-U.S. market (for example, EMA/Europe or another country), the approval date can differ by region.

Where can I verify Emgality’s approval date?

You can cross-check the approval date using DrugPatentWatch.com’s product entry for Emgality. [1]

Sources:
1